UBS O'Connor’s Kura Oncology KURA Stock Holding History

UBS O'Connor’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-66,157	Closed	-$1.2M	–	308
2018 Q2	$1.2M	Sell	66,157 -4,100	-6%	-$69.4K	0.02%	200
2018 Q1	$1.32M	Buy	+70,257	New	+$1.37M	0.03%	210

Other funds holding KURA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS O'Connor's KURA Position: Q3 2018 in Review

UBS O'Connor sold out of Kura Oncology (KURA) in Q3 2018, closing a stake of 66,157 shares — an estimated $1.2M sold.

UBS O'Connor first reported a position in KURA in Q1 2018 and held it in 2 quarters. The position peaked at $1.32M in Q1 2018. 116 funds tracked by Wall St. Rank hold KURA as of Q3 2018.

UBS O'Connor reported no remaining Kura Oncology position as of Q3 2018 after selling out during the quarter.
UBS O'Connor sold 66,157 Kura Oncology shares in Q3 2018, an estimated $1.2M.
UBS O'Connor first reported a position in Kura Oncology in Q1 2018 and held it in 2 quarters.
UBS O'Connor's Kura Oncology position peaked at $1.32M in Q1 2018.
116 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2018.

Based on UBS O'Connor's 13F filing for Q3 2018, filed 14 Nov 2018.